Vasoactive Drugs in Treatment of Shock

Abstract

There is still no proof that vasoactive drugs improve the survival of patients in shock, although they do produce hemodynamic changes judged to be favorable. In their present unproved state, vasoactive drugs should be considered as of secondary importance in treating shock. When circumstances require the use of a vasoactive drug, the agent of choice is a beta adrenergic stimulator.